Pilot Study of Auto-immune Abnormalities Associated With Down Syndrome (IMMUTRI)

I

Institut Jerome Lejeune

Status

Completed

Conditions

Down Syndrome With and Without Auto Immune Abnormalities

Study type

Observational

Funder types

Other

Identifiers

NCT01041469
IJL-IMM-EP10

Details and patient eligibility

About

The purpose of the study is to identify biological data linked to auto immune abnormalities associated with Down Syndrome.

Enrollment

72 patients

Sex

All

Ages

8 to 36 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Free and complete trisomy 21
  • aged between 8 and 36 years
  • biological or clinical signs of auto-immune disorder (group 1)
  • no sign of auto-immune disorder (group 2)

Exclusion criteria

  • any antimitotic or immune depressing treatment during the last 6 months
  • Current infectious disease
  • Corticosteroid therapy in the last 3 weeks
  • pregnancy

Trial design

72 participants in 2 patient groups

with abnormalities
Description:
Down syndrome patients presenting with at least one sign of auto immune abnormality
without abnormality
Description:
Down syndrome patients without any sign of recognized auto immune condition

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems